Overview
- Description
The company develops AI-based cardiac imaging technology to enhance personalized treatment for structural heart disease.
- Website
- Project
- Press Release
- Country
- Belgium
- Sector
- Medical Technologies
“This important milestone could only be reached by the continuous and high commitment from all our team members, the physicians who believe in our technology and other partners who support us in this journey. The EIC grant will not only boost our clinical and business implementation, but will also enable us to extend our device certifications.”
Matthieu De Beule, Co-founder & CEO
